Veterinary Medicines

Xylexx 20 mg/ml solution for injection for cattle, horses, dogs and cats

Authorised
  • Xylazine
Download as PDF

Product identification

Medicine name:
Xylexx 20 mg/ml solution for injection for cattle, horses, dogs and cats
Xylexx 20 mg/ml injekčný roztok pre hovädzí dobytok, kone, psy a mačky
Active substance:
  • Xylazine
Target species:
  • Cat
  • Cattle
  • Dog
  • Horse
Route of administration:
  • Subcutaneous use
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Xylazine
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
  • Intramuscular use
    • Cattle
      • Meat and offal
        1
        day
    • Dog
    • Cat
  • Intravenous use
    • Horse
      • Meat and offal
        1
        day
    • Cattle
      • Meat and offal
        1
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:
  • Clear type II glass vials containing 30 ml product, closed with a bromobutyl rubber stopper and aluminium cap in a polystyrene box.
  • Clear type II glass vials containing 30 ml product, closed with a bromobutyl rubber stopper and aluminium cap in a cardboard box
  • Clear type II glass vials containing 30 ml product, closed with a bromobutyl rubber stopper and aluminium cap in a cardboard or polystyrene box

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
Responsible authority:
  • USKVBL
Authorisation number:
  • 96/045/DC/22-S
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0366/001/DC
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 28/11/2022
Download
Slovak (PDF)
Published on: 23/05/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."